牛牛AI助手已提取核心信息
Vipin K Garg, President and CEO of Altimmune, Inc. [ALT], completed a series of stock transactions on February 1st and 2nd, 2024. Garg acquired a total of 35,495 shares of Altimmune common stock through the exercise of derivative securities at no cost. Concurrently, he disposed of 15,689 shares at prices ranging from $9.32 to $9.88 per share, resulting in a total market value of $150,316.76. Following these transactions, Garg's direct holdings in Altimmune amounted to 292,028 shares of common stock.
Vipin K Garg, President and CEO of Altimmune, Inc. [ALT], completed a series of stock transactions on February 1st and 2nd, 2024. Garg acquired a total of 35,495 shares of Altimmune common stock through the exercise of derivative securities at no cost. Concurrently, he disposed of 15,689 shares at prices ranging from $9.32 to $9.88 per share, resulting in a total market value of $150,316.76. Following these transactions, Garg's direct holdings in Altimmune amounted to 292,028 shares of common stock.
Altimmune, Inc. [ALT] 总裁兼首席执行官Vipin K Garg于2024年2月1日和2日完成了一系列股票交易。Garg通过免费行使衍生证券，共收购了35,495股Altimmune普通股。同时，他以每股9.32美元至9.88美元的价格出售了15,689股股票，总市值为150,316.76美元。这些交易之后，Garg在Altimmune的直接持有量为292,028股普通股。
Altimmune, Inc. [ALT] 总裁兼首席执行官Vipin K Garg于2024年2月1日和2日完成了一系列股票交易。Garg通过免费行使衍生证券，共收购了35,495股Altimmune普通股。同时，他以每股9.32美元至9.88美元的价格出售了15,689股股票，总市值为150,316.76美元。这些交易之后，Garg在Altimmune的直接持有量为292,028股普通股。
有用
没用